To further explore the beneficial activity and mechanism of action of PBA in ADTKD–SEC61A1 cells, we used sensitive Ca2+ imaging measurements and tested the response of the mutation-specific aberrations of Ca2+ homeostasis to PBA. The gene discussed is SEC61A1; the disease is autosomal dominant medullary cystic kidney disease with or without hyperuricemia.